Akanda Corp. AKAN stock skyrocketed today and it was trading 76.49% higher at $1.9591 at the time of writing Wednesday morning, following the Form F-20 filing with its FY 2022 earnings, revealing revenue of $2.6 million, an increase of 6223% compared to $41,431 in 2021.
FY 2022 Financial Highlights
-
Gross profit was $3.3 million compared to a gross loss of $1,591 in 2021.
-
Operating loss was $20.2 million compared to $2.6 million in 2021.
-
Net loss was $11.7 million compared to a loss of $8.1 million in 2021.
-
Cash and cash equivalents at the end of the year were $255,803, compared to $3.5 million in the prior year.
Recent Activity
The company announced on April 28th, that it has entered into a loan agreement with Veridia Canada Ltd., in the principal amount of €500,000 (approximately $551,000), which has been advanced in full by the lender. The loan is expected to be used for the short-term financial commitments of Akanda and Akanda’s wholly-owned company in Portugal, RPK Biopharma, Unipessoal, LDA, which is indirectly held by Akanda through Holigen Limited. Holigen is a directly held, wholly-owned subsidiary of the company.
Photo: Benzinga edit with photo by Kindel Media on Pexels
Related News
Canmart Ends CEO Service Agreement, Akanda Approves Appointment Of Director
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Date | ticker | name | Actual EPS | EPS Surprise | Actual Rev | Rev Surprise |
|---|
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Cannabis rescheduling seems to be right around the corner
Want to understand what this means for the future of the industry? Hear directly for top executives, investors and policymakers at the 19th Benzinga Cannabis Capital Conference, coming to Chicago this Oct. 8-9. Get your tickets now before prices surge by following this link.